Publication of List of Manufacturers Revoked from Licensing for the Manufacture of Therapeutic Goods - Reckitt Benckiser (Australia) Pty Ltd

Administered by Department of Health, Disability and Ageing

Legislation au C2013G01065 In force Gazette

Legislation content

 

 

THERAPEUTIC GOODS ACT 1989

 

 

PUBLICATION OF LIST OF MANUFACTURERS REVOKED FROM LICENSING FOR THE MANUFACTURE OF THERAPEUTIC GOODS

 

 

I, Bill Turner, delegate for the Secretary of the Department of Health and Ageing, Therapeutic Goods Administration, for  the purpose of section 41 of the Therapeutic Goods Act, hereby publish the following details concerning the revocation of a licence to manufacture therapeutic goods:

 

 

Under paragraph 41(1)(d) of the Therapeutic Goods Act 1989 the Secretary by notice in writing has revoked the licence held by:

 

 

 

 

Reckitt benckiser (australia) Pty limited – LICENCE NO MI-2012-LI-004912, ORIGINAL NUMBER 153297 – OF 44 wharf Road, west ryde nsw 2114 – at the request of the manufacturer.

 

 

 

 

 

 

 

 

 

 

(signed by)

 

 

Bill Turner

Office of Manufacturing Quality

Delegate of the Secretary

 

8 April 2013

 

Overview

The Therapeutic Goods Act 1989, enacted by the Commonwealth Parliament, serves to regulate the provision of therapeutic goods in Australia, ensuring their quality, safety, and efficacy. The Act establishes a framework for the approval, registration, and monitoring of therapeutic goods, including medicines, medical devices, and blood products. The revocation of a manufacturer’s licence under this Act addresses instances where a manufacturer fails to comply with the regulatory standards or voluntarily requests the revocation of their licence. This specific Gazette notice by the Therapeutic Goods Administration, dated 8 April 2013, announces the revocation of Reckitt Benckiser (Australia) Pty Limited's licence to manufacture therapeutic goods at their West Ryde facility, at the manufacturer's request. The objective of this revocation is to uphold the integrity and safety of the therapeutic goods market by removing non-compliant entities from the manufacturing process.

Scope and Application

The Therapeutic Goods Act 1989 applies to entities involved in the manufacture, supply, and distribution of therapeutic goods within Australia. This includes companies such as Reckitt Benckiser (Australia) Pty Limited, which must comply with the regulatory requirements outlined in the Act. The Act encompasses a wide range of therapeutic goods, including medicines, medical devices, and blood and blood components, ensuring they meet safety, quality, and efficacy standards before being made available to the public. The revocation of a manufacturer's licence, as demonstrated in the revocation of Reckitt Benckiser's licence under section 41(1)(d), is a measure taken by the Therapeutic Goods Administration to enforce compliance with the Act. The jurisdictional reach of the Act is national, with the Commonwealth government exercising oversight to regulate therapeutic goods across all states and territories in Australia. While the Act broadly applies to therapeutic goods manufacturers, certain exclusions and exemptions may apply, often defined through subordinate legislation or regulations that extend or refine the application of the primary Act.

Key Provisions

The Therapeutic Goods Act 1989, in particular section 41, provides for the revocation of a licence to manufacture therapeutic goods. This particular notice, published under section 41(1)(d), concerns the revocation of a licence held by Reckitt Benckiser (Australia) Pty Limited (ABN 15 000 978 528), located at 44 Wharf Road, West Ryde, NSW 2114. The original licence number was 153297, and the revoked licence number is MI-2012-LI-004912. This revocation was carried out at the request of the manufacturer, as per the requirements of the Act. The obligations and requirements of the Therapeutic Goods Act 1989 are broad and designed to ensure the safety and quality of therapeutic goods available in Australia. For manufacturers, this includes adhering to stringent manufacturing standards, maintaining accurate records, and ensuring that any therapeutic goods produced meet the standards set out in the Act. The revocation of a manufacturer's licence under section 41(1)(d) indicates that Reckitt Benckiser (Australia) Pty Limited no longer has the authority to manufacture therapeutic goods within Australia, as they have either voluntarily relinquished their licence or have not met the requirements set forth by the Act. Breaching the provisions of the Therapeutic Goods Act 1989 can lead to significant legal consequences. Offences under the Act can result in both civil and criminal penalties. For instance, knowingly manufacturing or supplying therapeutic goods that do not comply with the standards can result in criminal charges. The maximum penalties for such offences can include substantial fines and imprisonment. Specifically, for corporations, the fines can be as high as $1,100,000, and for individuals, the fines can reach up to $220,000, in addition to potential imprisonment terms. The revocation of a licence itself is a serious action, often resulting from a failure to comply with the Act’s requirements or from a deliberate breach of its provisions.

Legal classification tags

Area of Law
Medical Law
Instrument
Gazette Notice
Concepts
Definitions & Interpretation
Licensing & Registration
Offence Provisions

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.